| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tetralogy of Fallot | 14 | 2025 | 164 | 3.250 |
Why?
|
| Cardiac Surgical Procedures | 23 | 2025 | 1123 | 2.840 |
Why?
|
| Heart Defects, Congenital | 25 | 2024 | 1832 | 1.900 |
Why?
|
| Ventricular Outflow Obstruction | 8 | 2016 | 87 | 1.890 |
Why?
|
| Medical Errors | 4 | 2017 | 154 | 1.460 |
Why?
|
| Heart Valve Prosthesis Implantation | 10 | 2020 | 437 | 1.410 |
Why?
|
| Pulmonary Valve Insufficiency | 11 | 2025 | 41 | 1.360 |
Why?
|
| Heart Ventricles | 11 | 2023 | 783 | 1.260 |
Why?
|
| Aortic Valve | 5 | 2015 | 445 | 1.250 |
Why?
|
| Pulmonary Artery | 5 | 2017 | 438 | 1.070 |
Why?
|
| Pulmonary Valve | 6 | 2020 | 92 | 1.040 |
Why?
|
| Reoperation | 15 | 2021 | 830 | 1.000 |
Why?
|
| Pulmonary Valve Stenosis | 4 | 2020 | 40 | 0.880 |
Why?
|
| Heart-Assist Devices | 6 | 2024 | 1027 | 0.860 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2016 | 147 | 0.860 |
Why?
|
| Ventricular Function | 3 | 2015 | 91 | 0.840 |
Why?
|
| Heart Valve Diseases | 3 | 2016 | 174 | 0.800 |
Why?
|
| Heart Transplantation | 10 | 2024 | 859 | 0.780 |
Why?
|
| Vascular Surgical Procedures | 4 | 2021 | 554 | 0.770 |
Why?
|
| Hypoplastic Left Heart Syndrome | 7 | 2018 | 257 | 0.770 |
Why?
|
| Norwood Procedures | 4 | 2017 | 101 | 0.770 |
Why?
|
| Fontan Procedure | 7 | 2022 | 184 | 0.760 |
Why?
|
| Heart Failure | 8 | 2024 | 2299 | 0.750 |
Why?
|
| Cardiac Valve Annuloplasty | 2 | 2020 | 9 | 0.750 |
Why?
|
| Risk Assessment | 14 | 2025 | 3431 | 0.740 |
Why?
|
| Treatment Outcome | 36 | 2025 | 12287 | 0.740 |
Why?
|
| Blalock-Taussig Procedure | 3 | 2017 | 51 | 0.720 |
Why?
|
| Postoperative Complications | 10 | 2021 | 3056 | 0.640 |
Why?
|
| Echocardiography | 8 | 2019 | 1067 | 0.640 |
Why?
|
| Pilots | 1 | 2017 | 3 | 0.570 |
Why?
|
| Man-Machine Systems | 1 | 2017 | 7 | 0.570 |
Why?
|
| Aircraft | 1 | 2017 | 20 | 0.570 |
Why?
|
| Infant | 26 | 2024 | 12604 | 0.560 |
Why?
|
| Organ Sparing Treatments | 1 | 2017 | 36 | 0.560 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2019 | 374 | 0.560 |
Why?
|
| Surgical Flaps | 2 | 2017 | 203 | 0.560 |
Why?
|
| Attitude to Computers | 1 | 2017 | 49 | 0.560 |
Why?
|
| Follow-Up Studies | 17 | 2024 | 5171 | 0.550 |
Why?
|
| Infant, Newborn | 21 | 2019 | 8273 | 0.550 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 2 | 2021 | 27 | 0.520 |
Why?
|
| Humans | 78 | 2025 | 125362 | 0.520 |
Why?
|
| Survival Analysis | 10 | 2019 | 1495 | 0.440 |
Why?
|
| Abnormalities, Multiple | 3 | 2016 | 960 | 0.440 |
Why?
|
| Health Status | 3 | 2019 | 375 | 0.440 |
Why?
|
| Catheterization | 3 | 2012 | 227 | 0.440 |
Why?
|
| Retrospective Studies | 26 | 2024 | 16369 | 0.430 |
Why?
|
| Pulmonary Circulation | 2 | 2015 | 121 | 0.430 |
Why?
|
| Male | 44 | 2025 | 61566 | 0.410 |
Why?
|
| Time Factors | 16 | 2025 | 6311 | 0.400 |
Why?
|
| Tricuspid Valve Insufficiency | 4 | 2020 | 63 | 0.400 |
Why?
|
| Health Personnel | 1 | 2017 | 508 | 0.400 |
Why?
|
| Child | 22 | 2025 | 24617 | 0.390 |
Why?
|
| Survivors | 2 | 2012 | 339 | 0.380 |
Why?
|
| Female | 45 | 2025 | 66821 | 0.370 |
Why?
|
| Risk Factors | 17 | 2025 | 10298 | 0.370 |
Why?
|
| Age Factors | 7 | 2019 | 2818 | 0.360 |
Why?
|
| Adolescent | 22 | 2025 | 19430 | 0.360 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 855 | 0.360 |
Why?
|
| Adult | 28 | 2025 | 29543 | 0.360 |
Why?
|
| Graft Survival | 2 | 2024 | 532 | 0.360 |
Why?
|
| Bioprosthesis | 2 | 2010 | 111 | 0.350 |
Why?
|
| Infant, Premature | 2 | 2017 | 833 | 0.350 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 157 | 0.340 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2011 | 173 | 0.330 |
Why?
|
| Cyanosis | 1 | 2010 | 42 | 0.320 |
Why?
|
| Child, Preschool | 13 | 2024 | 14151 | 0.320 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2023 | 76 | 0.320 |
Why?
|
| Palliative Care | 7 | 2017 | 433 | 0.320 |
Why?
|
| Databases, Factual | 2 | 2017 | 1172 | 0.310 |
Why?
|
| Aorta | 2 | 2015 | 545 | 0.310 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2010 | 91 | 0.310 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2008 | 21 | 0.300 |
Why?
|
| Saphenous Vein | 1 | 2008 | 59 | 0.300 |
Why?
|
| Aortic Valve Stenosis | 2 | 2012 | 338 | 0.300 |
Why?
|
| Vascular Fistula | 1 | 2008 | 31 | 0.300 |
Why?
|
| Truncus Arteriosus | 1 | 2008 | 13 | 0.290 |
Why?
|
| Aneurysm | 1 | 2008 | 90 | 0.290 |
Why?
|
| Brain Injuries | 2 | 2019 | 702 | 0.290 |
Why?
|
| Jugular Veins | 1 | 2008 | 76 | 0.290 |
Why?
|
| Cardiac Catheterization | 6 | 2019 | 633 | 0.290 |
Why?
|
| Prognosis | 9 | 2019 | 4686 | 0.280 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2025 | 160 | 0.280 |
Why?
|
| Tracheal Stenosis | 1 | 2007 | 30 | 0.270 |
Why?
|
| Diverticulum | 1 | 2007 | 29 | 0.270 |
Why?
|
| Ischemic Preconditioning | 1 | 2007 | 19 | 0.270 |
Why?
|
| Endocarditis, Bacterial | 1 | 2008 | 136 | 0.270 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2007 | 40 | 0.270 |
Why?
|
| Subclavian Artery | 1 | 2007 | 71 | 0.270 |
Why?
|
| Prosthesis Implantation | 1 | 2008 | 140 | 0.260 |
Why?
|
| Oxygen Consumption | 3 | 2019 | 305 | 0.260 |
Why?
|
| Ontario | 3 | 2017 | 73 | 0.260 |
Why?
|
| United States National Aeronautics and Space Administration | 2 | 2016 | 17 | 0.250 |
Why?
|
| Quality of Life | 4 | 2023 | 1909 | 0.250 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 297 | 0.240 |
Why?
|
| Pediatrics | 1 | 2014 | 1158 | 0.240 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2022 | 282 | 0.240 |
Why?
|
| Coronary Artery Bypass | 1 | 2008 | 516 | 0.230 |
Why?
|
| Pulmonary Veins | 2 | 2021 | 162 | 0.230 |
Why?
|
| Aortic Diseases | 1 | 2007 | 197 | 0.230 |
Why?
|
| Societies, Medical | 1 | 2008 | 700 | 0.230 |
Why?
|
| Epidemiologic Methods | 3 | 2009 | 108 | 0.230 |
Why?
|
| Young Adult | 11 | 2025 | 9061 | 0.230 |
Why?
|
| Cohort Studies | 7 | 2020 | 4828 | 0.220 |
Why?
|
| Survival Rate | 5 | 2017 | 2050 | 0.220 |
Why?
|
| Heart Diseases | 1 | 2008 | 496 | 0.220 |
Why?
|
| Middle Aged | 17 | 2025 | 26763 | 0.210 |
Why?
|
| Transplantation, Homologous | 3 | 2011 | 621 | 0.210 |
Why?
|
| Allografts | 1 | 2024 | 176 | 0.210 |
Why?
|
| Tricuspid Valve | 2 | 2015 | 61 | 0.210 |
Why?
|
| Biomedical Research | 1 | 2008 | 518 | 0.200 |
Why?
|
| Aorta, Thoracic | 1 | 2007 | 526 | 0.200 |
Why?
|
| Embolism, Air | 1 | 2022 | 24 | 0.200 |
Why?
|
| Double Outlet Right Ventricle | 2 | 2020 | 22 | 0.190 |
Why?
|
| Models, Statistical | 2 | 2016 | 471 | 0.190 |
Why?
|
| Fetus | 2 | 2016 | 586 | 0.190 |
Why?
|
| Severity of Illness Index | 6 | 2014 | 2909 | 0.190 |
Why?
|
| Prospective Studies | 9 | 2025 | 6141 | 0.180 |
Why?
|
| Tachycardia, Supraventricular | 2 | 2019 | 109 | 0.180 |
Why?
|
| Heterotaxy Syndrome | 1 | 2021 | 60 | 0.170 |
Why?
|
| Long Term Adverse Effects | 1 | 2020 | 12 | 0.170 |
Why?
|
| Scimitar Syndrome | 1 | 2021 | 52 | 0.170 |
Why?
|
| Graft Rejection | 1 | 2024 | 588 | 0.170 |
Why?
|
| Dextrocardia | 1 | 2020 | 9 | 0.170 |
Why?
|
| Myocardium | 3 | 2024 | 1022 | 0.170 |
Why?
|
| Heart Valve Prosthesis | 2 | 2016 | 302 | 0.170 |
Why?
|
| Situs Inversus | 1 | 2020 | 26 | 0.170 |
Why?
|
| Canada | 5 | 2020 | 286 | 0.170 |
Why?
|
| Macrophages | 1 | 2024 | 626 | 0.170 |
Why?
|
| Critical Care | 2 | 2019 | 656 | 0.160 |
Why?
|
| Terminal Care | 1 | 2019 | 112 | 0.150 |
Why?
|
| Ventricular Remodeling | 1 | 2018 | 184 | 0.140 |
Why?
|
| Patient Care Team | 2 | 2022 | 543 | 0.140 |
Why?
|
| Liver Diseases | 1 | 2021 | 368 | 0.140 |
Why?
|
| Automation | 1 | 2017 | 64 | 0.140 |
Why?
|
| Disease Management | 2 | 2019 | 530 | 0.140 |
Why?
|
| Length of Stay | 3 | 2020 | 1310 | 0.140 |
Why?
|
| Cardiology | 1 | 2022 | 507 | 0.140 |
Why?
|
| Operative Time | 1 | 2017 | 165 | 0.140 |
Why?
|
| Ventricular Dysfunction | 1 | 2017 | 25 | 0.130 |
Why?
|
| Coronary Vessels | 2 | 2015 | 531 | 0.130 |
Why?
|
| Simulation Training | 1 | 2019 | 140 | 0.130 |
Why?
|
| Catheter Ablation | 1 | 2019 | 233 | 0.130 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 473 | 0.130 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2017 | 118 | 0.130 |
Why?
|
| Ventricular Function, Left | 2 | 2023 | 514 | 0.130 |
Why?
|
| Ventricular Function, Right | 3 | 2023 | 113 | 0.120 |
Why?
|
| Brain | 3 | 2019 | 3014 | 0.120 |
Why?
|
| Stroke | 1 | 2023 | 983 | 0.120 |
Why?
|
| Equipment Design | 1 | 2017 | 589 | 0.120 |
Why?
|
| Tricuspid Atresia | 1 | 2015 | 13 | 0.120 |
Why?
|
| Propensity Score | 1 | 2016 | 222 | 0.120 |
Why?
|
| Patient Selection | 2 | 2009 | 696 | 0.120 |
Why?
|
| Surgeons | 1 | 2019 | 257 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 1 | 2019 | 439 | 0.110 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 522 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2019 | 578 | 0.110 |
Why?
|
| Stents | 3 | 2016 | 835 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 500 | 0.110 |
Why?
|
| Registries | 2 | 2025 | 1434 | 0.110 |
Why?
|
| United States | 4 | 2016 | 10909 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2019 | 648 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2015 | 1017 | 0.100 |
Why?
|
| Heart Aneurysm | 1 | 2013 | 37 | 0.100 |
Why?
|
| Birth Weight | 2 | 2016 | 346 | 0.100 |
Why?
|
| Renal Dialysis | 1 | 2019 | 862 | 0.100 |
Why?
|
| Heart Septal Defects | 2 | 2012 | 38 | 0.100 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2012 | 42 | 0.100 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2013 | 40 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1269 | 0.100 |
Why?
|
| Ductus Arteriosus | 1 | 2013 | 62 | 0.100 |
Why?
|
| Heart Atria | 2 | 2019 | 321 | 0.100 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2012 | 70 | 0.100 |
Why?
|
| Thrombosis | 1 | 2017 | 524 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2025 | 2182 | 0.090 |
Why?
|
| Aged | 4 | 2021 | 19722 | 0.090 |
Why?
|
| Aortic Coarctation | 1 | 2012 | 110 | 0.090 |
Why?
|
| Terminology as Topic | 1 | 2012 | 224 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2008 | 2096 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2025 | 3605 | 0.080 |
Why?
|
| Arteriovenous Malformations | 1 | 2010 | 47 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2011 | 193 | 0.080 |
Why?
|
| Vena Cava, Superior | 1 | 2010 | 60 | 0.080 |
Why?
|
| Viridans Streptococci | 1 | 2008 | 8 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2019 | 1183 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 3408 | 0.080 |
Why?
|
| Coronary Circulation | 2 | 2009 | 211 | 0.080 |
Why?
|
| Williams Syndrome | 1 | 2008 | 41 | 0.080 |
Why?
|
| Pulmonary Atresia | 1 | 2008 | 47 | 0.070 |
Why?
|
| Angiography | 1 | 2008 | 210 | 0.070 |
Why?
|
| Heat-Shock Proteins | 2 | 1999 | 196 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 1999 | 210 | 0.070 |
Why?
|
| Phenotype | 1 | 2017 | 4270 | 0.070 |
Why?
|
| Echocardiography, Doppler | 1 | 2008 | 171 | 0.070 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 77 | 0.070 |
Why?
|
| Time | 1 | 2008 | 92 | 0.070 |
Why?
|
| Mitral Valve | 1 | 2009 | 252 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 141 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 261 | 0.070 |
Why?
|
| Prosthesis Failure | 1 | 2008 | 156 | 0.070 |
Why?
|
| Respiratory Sounds | 1 | 2007 | 70 | 0.070 |
Why?
|
| Cattle | 1 | 2008 | 567 | 0.070 |
Why?
|
| Hospital Mortality | 3 | 2019 | 1027 | 0.070 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2007 | 118 | 0.070 |
Why?
|
| Swine | 2 | 2007 | 1179 | 0.070 |
Why?
|
| Bronchoscopy | 1 | 2007 | 153 | 0.070 |
Why?
|
| Endocarditis | 1 | 2007 | 106 | 0.060 |
Why?
|
| Dyspnea | 1 | 2007 | 153 | 0.060 |
Why?
|
| Streptococcal Infections | 1 | 2008 | 241 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 2 | 2022 | 463 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 330 | 0.060 |
Why?
|
| Cell Survival | 1 | 2007 | 821 | 0.060 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2005 | 53 | 0.060 |
Why?
|
| Prosthesis Design | 1 | 2008 | 668 | 0.060 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2017 | 112 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2005 | 163 | 0.060 |
Why?
|
| Comorbidity | 2 | 2019 | 1528 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 225 | 0.050 |
Why?
|
| Decision Making | 1 | 2008 | 657 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2007 | 1018 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2008 | 562 | 0.050 |
Why?
|
| Animals | 6 | 2019 | 34319 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 1465 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 86 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 117 | 0.050 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 3688 | 0.050 |
Why?
|
| Organizational Culture | 1 | 2022 | 95 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2880 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 275 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 327 | 0.050 |
Why?
|
| Perfusion | 1 | 2022 | 206 | 0.050 |
Why?
|
| Shock, Cardiogenic | 1 | 2022 | 193 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2023 | 496 | 0.040 |
Why?
|
| Algorithms | 1 | 2007 | 1633 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2021 | 338 | 0.040 |
Why?
|
| Machine Learning | 1 | 2023 | 251 | 0.040 |
Why?
|
| Leadership | 1 | 2022 | 230 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2020 | 73 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 245 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2022 | 449 | 0.040 |
Why?
|
| Tachycardia | 1 | 2019 | 70 | 0.040 |
Why?
|
| Models, Anatomic | 1 | 2020 | 100 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 1999 | 136 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 295 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2020 | 248 | 0.040 |
Why?
|
| Printing, Three-Dimensional | 1 | 2019 | 69 | 0.040 |
Why?
|
| Incidence | 2 | 2017 | 3134 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2019 | 185 | 0.040 |
Why?
|
| Transposition of Great Vessels | 1 | 2019 | 132 | 0.040 |
Why?
|
| Heart | 1 | 2022 | 731 | 0.040 |
Why?
|
| Pregnancy | 3 | 2016 | 7226 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 1394 | 0.030 |
Why?
|
| Models, Animal | 1 | 2019 | 456 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2019 | 354 | 0.030 |
Why?
|
| Fibrosis | 1 | 2018 | 442 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 265 | 0.030 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2019 | 313 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2019 | 650 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2014 | 1399 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2019 | 343 | 0.030 |
Why?
|
| Cell Movement | 1 | 1999 | 854 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1240 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 1999 | 345 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 880 | 0.030 |
Why?
|
| Biopsy | 1 | 2018 | 1244 | 0.030 |
Why?
|
| Replantation | 1 | 2015 | 55 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2015 | 120 | 0.030 |
Why?
|
| Vascular Patency | 1 | 2015 | 192 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2015 | 209 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2016 | 433 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 473 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 442 | 0.030 |
Why?
|
| Curriculum | 1 | 2019 | 728 | 0.030 |
Why?
|
| Oximetry | 1 | 2015 | 171 | 0.030 |
Why?
|
| Oxygen | 1 | 2017 | 556 | 0.030 |
Why?
|
| Gestational Age | 1 | 2017 | 1169 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 2084 | 0.030 |
Why?
|
| Rupture, Spontaneous | 1 | 2013 | 49 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 2467 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1065 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2019 | 1001 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2017 | 978 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2013 | 126 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 778 | 0.020 |
Why?
|
| Siblings | 1 | 2012 | 186 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2015 | 849 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2017 | 617 | 0.020 |
Why?
|
| Cineangiography | 1 | 2009 | 16 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2009 | 41 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 2009 | 167 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 1999 | 126 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1427 | 0.020 |
Why?
|
| Angioplasty, Balloon | 1 | 2009 | 155 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3313 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1802 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2009 | 301 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 972 | 0.020 |
Why?
|
| Exercise | 1 | 2012 | 814 | 0.020 |
Why?
|
| Computer Systems | 1 | 2005 | 37 | 0.020 |
Why?
|
| Phosphorylation | 2 | 1999 | 1639 | 0.010 |
Why?
|
| Fluorocarbons | 1 | 2005 | 55 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2005 | 454 | 0.010 |
Why?
|
| Contrast Media | 1 | 2005 | 480 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1999 | 43 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1999 | 142 | 0.010 |
Why?
|
| Dogs | 1 | 1999 | 773 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1999 | 465 | 0.010 |
Why?
|
| Adenoviridae | 1 | 1999 | 605 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 1243 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1999 | 3044 | 0.010 |
Why?
|
| Rats | 1 | 1999 | 3729 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1999 | 4595 | 0.000 |
Why?
|